AngioScore

📍 Fremont, United States🗓 Founded 2003👥 58 employees💰 Last funded Feb 2014
Medical Equipment Manufacturing🌐 angioscore.com
Website LinkedIn
The AngioSculpt Scoring Balloon Catheter significantly alters the landscape for treating both peripheral arterial disease (PAD) and coronary artery disease (CAD). The innovative nitinol scoring element scores the plaque circumferentially, providing a precise and predictable dilatation across a wide range of lesion types. AngioSculpt provides the versatility and effectiveness of a new technology together with the simplicity and deliverability of a high-performance balloon catheter.
2
Total investors
0
Early stage
0
Mid stage
1
Late stage
2003
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Frequently asked questions
Who invested in AngioScore?
AngioScore has 2 investors on record on gritt.io and 1 late-stage investors.
When did AngioScore last raise funding?
The most recent investment in AngioScore recorded on gritt.io was in February 2014.
When was AngioScore founded?
AngioScore was founded in 2003.
What industry is AngioScore in?
AngioScore operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is AngioScore based?
AngioScore is headquartered in Fremont, United States.